301.694.2999

DONATE

U.S. FDA GRANTS THERADAPTIVE IDE APPROVAL FOR PHASE I/II CLINICAL TRIALS

By

|

Global study will assess the safety and efficacy of the company’s lead spinal fusion product, OsteoAdapt SP FREDERICK, Md., Feb. 1, 2024  — FITCI graduate Theradaptive, the market leader in targeted regenerative therapeutics, has gained approval from the U.S. Food and Drug Administration (FDA) for their Investigational Device Exemption (IDE) submission to begin enrolling patients into OASIS, … Read more

KnowledgeNet.ai Expands its Reach with 20th CRM Partnership Milestone

By

|

FREDERICK MD – KnowledgeNet.ai, a leading provider of artificial intelligence solutions, proudly announces a significant milestone in its continued growth and market presence. The company has reached its 20th Customer Relationship Management (CRM) partnership, marking a significant achievement in its mission to empower businesses with cutting-edge AI technologies. In a landscape where organizations increasingly seek … Read more

FITCI Seeks Consultant for Regional Entrepreneurship Economic Assessment

By

|

1/05/2024 – Frederick Innovative Technology Center, Inc. (FITCI) is a business incubator and accelerator designed to cultivate entrepreneurship in Frederick, Maryland. It offers coaching, connections, access to capital, and customers for its members, including various programs, classes, and facilities. FITCI, along with the Harford County Office of Economic Development (HCOED), have joined the Mid-Atlantic Gigabit … Read more

Meridian BioGroup acquired by Pace® Life Sciences

Expanding Regulatory, Compliance, and Validation Capabilities to the Biotechnology and Pharmaceutical Markets

By

Meridian BioGroup

|

We are excited to announce, that Meridian BioGroup has been acquired by Pace® Life Sciences. The acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated environments. President of Pace® Life Sciences Greg Kupp said, “The addition of the Meridian BioGroup team … Read more

A single injection hepatitis B cure attracts international attention

Dr. Yong-Yuan Zhang presents in Paris, Seoul, and Washington DC in 2022

By

April Bartel

|

Frederick, MD – HBVtech, a biopharma startup company within the Frederick Innovation Technology Center (FITCI), is garnering international attention for its work creating a single-dose injection-based hepatitis B cure. Founder and Chief Science Officer, Dr. Yong-Yuan Zhang is well known for his research and writing on the topic of hepatitis, including related functional genomics and … Read more

AFFORDABLE POINT OF SERVICE HEALTHCARE ACCESS COMES TO MARYLANDERS

MARYLAND BUSINESSES PARTNERSHIP TO PROVIDE TELEHEALTH PLATFORM TO MITIGATE HEALTH INEQUITY

By

Ashok Kapur, Hawkeye MedTech

|

Columbia, MD, July 18, 2022 – Hawkeye Med Tech, Inc, a Maryland Medtech company has partnered with the Kiosk Group, Ltd,. to produce one-of-a-kind Portable TotalCare Telehealth StationTM or PTTS. PTTS is a Made in Maryland integrated telehealth tablet, blood pressure machine and pulse oximeter. PTTS not only enables users to get scheduled virtual medical and mental … Read more

Mesa Science Associates Receives Grant to Study Marfan Syndrome Treatment

Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Marfan Syndrome: Phase I Pharmacokinetic Studies

By

Mesa Associates, Inc.

|

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of Health (NIH) entitled “Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Marfan Syndrome: Phase I Pharmacokinetic Studies.”Upon receiving this notification, Mr. Michael Mesa, President of MSA, “stated that this grant results from … Read more

FITCI Grad BioFactura Announces Activation of a $15.9M Contract Option

Smallpox Biodefense Therapeutic, contract valued at up to $68.2 million

By

Darryl Sampey, Ph.D., CEO

|

FREDERICK, MARYLAND, JULY 14, 2022: BioFactura today announced its second contract option activation of $15.9 million from the Biomedical Advanced Research and Development Authority (BARDA) to advance development of an antibody cocktail therapeutic for the treatment of smallpox. This funding is part of BioFactura’s prime contract valued at up to $68.2 million for the advanced … Read more

TEDCO Invests in FITCI Member, Alirtify, a Rural Maryland Pre-Seed Company

Alirtify is an intelligence-gathering platform

By

Tammi Thomas, Chief Marketing & Communications Officer, TEDCO tthomas@tedco.md

|

July 5, 2022—TEDCO, Maryland’s economic engine for technology companies (and a FITCI founding partner), announced today that its Rural Business Innovation Initiative (RBII) made a $25,000 investment in Alirtify, an intelligence-gathering platform based in Frederick, Md. “This new funding from TEDCO will help Alirtify expand and move its platform to the next level,” said Chuck Ernst, RBII mentor, Western … Read more

THERADAPTIVE: shaping the future of regenerative medicine at military treatment facilities

Advanced theraputic can mean the difference between amputation and limb preservation

By

The Geneva Foundation

|

Theradaptive is shaping the future of regenerative medicine with a new platform to deliver therapeutics that promote targeted native tissue repair. Their lead therapeutic, AMP2, is applied to an orthopedic implant to regenerate damaged bone, therefore significantly helping to speed up the injury healing process. For service members with combat trauma this can mean the … Read more